UBS AM’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-48,900
| Closed | -$298K | – | 2720 |
|
|
2022
Q4 | $298K | Buy |
+48,900
| New | +$298K | ﹤0.01% | 2330 |
|
|
2021
Q2 | – | Sell |
-26,231
| Closed | -$124K | – | 2782 |
|
|
2021
Q1 | $124K | Buy |
26,231
+12,222
| +87% | +$57.6K | ﹤0.01% | 2586 |
|
|
2020
Q4 | $100K | Hold |
14,009
| – | – | ﹤0.01% | 2534 |
|
|
2020
Q3 | $149K | Hold |
14,009
| – | – | ﹤0.01% | 2438 |
|
|
2020
Q2 | $177K | Hold |
14,009
| – | – | ﹤0.01% | 2412 |
|
|
2020
Q1 | $128K | Sell |
14,009
-279,967
| -95% | -$2.56M | ﹤0.01% | 2368 |
|
|
2019
Q4 | $4.1M | Sell |
293,976
-18,945
| -6% | -$264K | ﹤0.01% | 1277 |
|
|
2019
Q3 | $5.39M | Buy |
312,921
+2,839
| +0.9% | +$48.9K | ﹤0.01% | 1178 |
|
|
2019
Q2 | $8.44M | Buy |
310,082
+10,688
| +4% | +$291K | 0.01% | 1008 |
|
|
2019
Q1 | $5.73M | Sell |
299,394
-13,505
| -4% | -$258K | ﹤0.01% | 1101 |
|
|
2018
Q4 | $2.94M | Sell |
312,899
-22,772
| -7% | -$214K | ﹤0.01% | 1279 |
|
|
2018
Q3 | $6.35M | Buy |
335,671
+7,841
| +2% | +$148K | ﹤0.01% | 1066 |
|
|
2018
Q2 | $6.41M | Buy |
327,830
+60,728
| +23% | +$1.19M | ﹤0.01% | 1066 |
|
|
2018
Q1 | $5.02M | Sell |
267,102
-1,053
| -0.4% | -$19.8K | ﹤0.01% | 1145 |
|
|
2017
Q4 | $4.45M | Buy |
+268,155
| New | +$4.45M | ﹤0.01% | 1159 |
|